2227. Short-Duration of Direct-Acting Antivirals in Hepatitis C Virus-Infected Cancer Patients

BACKGROUND: Short-duration with an 8-week course of ledipasvir/sofosbuvir (LDV/SOF) or glecaprevir/pibrentasvir (GLE/PIB) is considered adequate to treat hepatitis C virus (HCV) infection in selected patients. However, immunocompromised patients with HCV/HIV are not eligible for this approach. Herei...

全面介紹

Na minha lista:
書目詳細資料
發表在:Open Forum Infect Dis
Main Authors: Hosry, Jeff, Angelidakis, Georgios, Granwehr, Bruno, Torres, Harrys
格式: Artigo
語言:Inglês
出版: Oxford University Press 2018
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253132/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1880
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍